A year ago, he became one of just 200 people selected to take part in the trial of a new asthma treatment, Benralizumab, that ...

University of Pittsburgh researchers have developed a new nasal swab test to determine Asthma subtype results for kids. The ...

A novel diagnostic test using just a nasal swab could transform how doctors diagnose and treat childhood asthma. Researchers ...

The tool, developed by researchers at Pitt, could allow doctors to diagnose subtypes of the disease without putting patients ...

Researchers at the University of Pittsburgh have developed a new nasal swab test that identifies specific asthma subtypes in ...

Broncho-Vaxom is under clinical development by OM Pharma and currently in Phase I for Allergic Asthma. According to GlobalData, Phase I drugs for Allergic Asthma have a 78% phase transition success ...

Opens in a new tab or window Despite a declining trend, the number of adults in the U.S. who say they did not adhere to their asthma treatment because of costs remains high, according to an ...

Researchers have unveiled a groundbreaking nasal swab test for diagnosing specific asthma endotypes in children, particularly ...

Research using nasal swabs to identify asthma subtypes promises precise treatment. T2-high asthma may be less common than T2-low, suggesting a need for new treatments. Meanwhile, insights into why ...

Omalizumab biosimilar is under clinical development by Mabpharm and currently in Phase III for Chronic Urticaria Or Hives.

The China National Medical Products Administration (NMPA) has approved GSK’s Nucala (mepolizumab) as an add-on treatment with ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/95.C_N2kNfW.js ...